Ex parte EISENHARDT et al. - Page 6




              Appeal No. 1999-1229                                                                                      
              Application 08/543,975                                                                                    
              and enable release only in the duodenum.  Id., col. 2, lines 43-58.  Although never                       
              mentioned by the examiner, we note that Sipos discloses that lactases from microbial                      
              sources are suitable enzymes which can be formulated into an enterically-coated                           
              composition.  Id., col. 5, lines 35-37.                                                                   
                     According to the examiner [Answer, pp. 5-6]:                                                       
                     Clearly, the prior art motivates one of ordinary skill in the art to formulate a lactase           
              enzyme in the treatment of lactose intolerance and to facilitate the hydrolysis of lactose in             
              mammals.  The claims differ from the teachings of Barillas, Medow and Rosado in that                      
              none of the references teach the combination of the two lactases together in a solid, orally              
              administrable formulation.  However, in view of the teaching of the prior art taken as a                  
              whole, the practitioner would reasonably expect that a “superior processing effect” (per the              
              teaching of Kan) would be obtained in vivo as well as in vitro by administering both                      
              enzymes together as the prior art acknowledges that one of ordinary skill in the art is well              
              aware of the teachings of Rosado which show that either enzyme is individually effective                  
              when administered alone.  Therefore, it would have been obvious per the disclosure of Kan                 
              et al. to optimize the degree of lactose hydrolysis by the administration of two different                
              lactase enzymes having different optimum pH ranges for the purpose of maximizing the                      
              amount of lactase hydrolysis as the lactase travels from the stomach and the intestine.                   
              Each lactase enzyme is well known for both its activity and optimum pH range.                             
                     It is well established that the examiner has the initial burden under § 103 to establish           
              a prima facie case of obviousness.  In re Oetiker, 977 F.2d 1443, 1445,                                   
              24 USPQ2d 1443, 1444 (Fed. Cir. 1992); In re Piasecki, 745 F.2d 1468, 1471-72,                            
              223 USPQ 785, 787-88 (Fed. Cir. 1984).  It is the examiner’s responsibility to show that                  
              some objective teaching or suggestion in the applied prior art, or knowledge generally                    
              available [in the art] would have led one of ordinary skill in the art to combine the references          
              to arrive at the claimed invention.  Pro-Mold & Tool Co. v. Great Lakes Plastics, Inc., 745               



                                                           6                                                            





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007